{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:48:36Z","timestamp":1791686916989,"version":"4.3.4"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00467","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:57:10Z","timestamp":1599008230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":107,"title":["Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases"],"prefix":"10.3389","volume":"7","author":[{"given":"Pooja","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder K.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Saksena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waddah A.","family":"Alrefai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/hep.26088","article-title":"Cholesterol and NAFLD: renewed focus on an old villain","volume":"56","author":"Kerr","year":"2012","journal-title":"Hepatol Baltim Md."},{"key":"B4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic fatty liver disease: dyslipidemia, risk for cardiovascular complications, and treatment strategy","volume":"3","author":"Zhang","year":"2015","journal-title":"J Clin Transl Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab."},{"key":"B7","first-page":"xii","volume-title":"Cholesterol, Chemistry, Biochemistry And Pathology","author":"Cook","year":"1958"},{"key":"B8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4254\/wjh.v8.i22.924","article-title":"Cholesterol metabolism in cholestatic liver disease and liver transplantation: from molecular mechanisms to clinical implications","volume":"8","author":"Nemes","year":"2016","journal-title":"World J Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.physiol.69.031905.160725","article-title":"Regulation of intestinal cholesterol absorption","volume":"69","author":"Wang","year":"2007","journal-title":"Annu Rev Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"G369","DOI":"10.1152\/ajpgi.00306.2006","article-title":"Modulation of human niemann-Pick C1-like 1 gene expression by sterol: role of sterol regulatory element binding protein 2","volume":"292","author":"Alrefai","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/cphy.c190007","article-title":"Intestinal absorption of bile acids in health and disease","volume":"10","author":"Ticho","year":"2019","journal-title":"Compr Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig Dis Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00000441-200512000-00011","article-title":"Nonalcoholic steatohepatitis and the metabolic syndrome","volume":"330","author":"Neuschwander-Tetri","year":"2005","journal-title":"Am J Med Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pharmthera.2014.09.009","article-title":"Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine","volume":"146","author":"Fan","year":"2015","journal-title":"Pharmacol Ther."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J Lipid Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e97841","DOI":"10.1371\/journal.pone.0097841","article-title":"Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/01.ATV.20.11.2336","article-title":"Genetic modifiers of atherosclerosis in mice","volume":"20","author":"Knowles","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12931","DOI":"10.1038\/srep12931","article-title":"Seven weeks of western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"Schierwagen","year":"2015","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"R200","DOI":"10.1186\/gb-2007-8-9-r200","article-title":"Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis","volume":"8","author":"Kleemann","year":"2007","journal-title":"Genome Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.25789","article-title":"Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis","volume":"57","author":"Savard","year":"2013","journal-title":"Hepatol Baltim Md."},{"key":"B23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/hep.22904","article-title":"Nutritional model of steatohepatitis and metabolic syndrome in the ossabaw miniature swine","volume":"50","author":"Lee","year":"2009","journal-title":"Hepatol Baltim Md."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatol Baltim Md."},{"key":"B25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and fas-mediated steatohepatitis","volume":"4","author":"Mar\u00ed","year":"2006","journal-title":"Cell Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J Lipid Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.gastro.2012.09.062","article-title":"The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice","volume":"144","author":"Bieghs","year":"2013","journal-title":"Gastroenterology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2548154","DOI":"10.1155\/2018\/2548154","article-title":"Hypoxic signaling and cholesterol lipotoxicity in fatty liver disease progression","volume":"2018","author":"Tirosh","year":"2018","journal-title":"Oxid Med Cell Longev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2014.03.018","article-title":"Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells","volume":"61","author":"Tomita","year":"2014","journal-title":"J Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jcmm.12223","article-title":"The functional role of microRNAs in alcoholic liver injury","volume":"18","author":"McDaniel","year":"2014","journal-title":"J Cell Mol Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.trsl.2011.01.008","article-title":"MicroRNAs and liver disease","volume":"157","author":"Kerr","year":"2011","journal-title":"Transl Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOL.0000000000000420","article-title":"microRNAs and lipid metabolism","volume":"28","author":"Aryal","year":"2017","journal-title":"Curr Opin Lipidol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-081810-160756","article-title":"The role of microRNAs in cholesterol efflux and hepatic lipid metabolism","volume":"31","author":"Moore","year":"2011","journal-title":"Annu Rev Nutr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/aps.2016.158","article-title":"Dicer 1 \/miR-29\/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis","volume":"38","author":"Liu","year":"2017","journal-title":"Acta Pharmacol Sin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on cholesterol homeostasis: the central role of scap","volume":"87","author":"Brown","year":"2018","journal-title":"Annu Rev Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1440-1746.2011.06704.x","article-title":"SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH","volume":"26","author":"Rooyen","year":"2011","journal-title":"J Gastroenterol Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1440-1746.2010.06560.x","article-title":"Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis","volume":"26","author":"Zhao","year":"2011","journal-title":"J Gastroenterol Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatol Baltim Md."},{"key":"B40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1210\/me.2007-0531","article-title":"Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs","volume":"23","author":"Xie","year":"2009","journal-title":"Mol Endocrinol Baltim Md."},{"key":"B41","doi-asserted-by":"publisher","first-page":"G376","DOI":"10.1152\/ajpgi.00174.2017","article-title":"Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis","volume":"313","author":"Malhotra","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hep.22941","article-title":"Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population","volume":"50","author":"Ioannou","year":"2009","journal-title":"Hepatol Baltim Md."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"J Lipid Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2010.05.037","article-title":"Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity","volume":"54","author":"Simonen","year":"2011","journal-title":"J Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00125-006-0177-8","article-title":"Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of niemann-pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein","volume":"49","author":"Lally","year":"2006","journal-title":"Diabetologia."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMe1507041","article-title":"Proof that lower is better \u2014 ldl cholesterol and IMPROVE-IT","volume":"372","author":"Jarcho","year":"2015","journal-title":"N Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15386\/cjmed-277","article-title":"From NAFLD to cardiovascular disease. Is it (still) the metabolic syndrome?","volume":"87","author":"Munteanu","year":"2014","journal-title":"Clujul Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and non-alcoholic steatohepatitis in at risk individuals","volume":"63","author":"Dongiovanni","year":"2015","journal-title":"J Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jhep.2013.02.005","article-title":"Simvastatin maintains function and viability of steatotic rat livers procured for transplantation","volume":"58","author":"Gracia-Sancho","year":"2013","journal-title":"J Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12876-015-0248-8","article-title":"Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells","volume":"15","author":"Chong","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"G724","DOI":"10.1152\/ajpgi.00063.2016","article-title":"Statins improve NASH via inhibition of RhoA and Ras","volume":"311","author":"Schierwagen","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against non-alcoholic fatty liver disease in high fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci Transl Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0218459","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-\/-.Leiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLoS ONE."},{"key":"B56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.024","article-title":"Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study","volume":"73","author":"Newsome","year":"2020","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.metabol.2010.06.008","article-title":"Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet","volume":"60","author":"Muraoka","year":"2011","journal-title":"Metabolism."},{"key":"B58","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s00125-013-3149-9","article-title":"The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial","volume":"57","author":"Takeshita","year":"2014","journal-title":"Diabetologia."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatol Baltim Md."},{"key":"B60","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3904\/kjim.2017.194","article-title":"Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis","volume":"34","author":"Lee","year":"2019","journal-title":"Korean J Intern Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1210\/jc.2003-030388","article-title":"Medical management of hyperlipidemia\/dyslipidemia","volume":"88","author":"Kreisberg","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cgh.2006.04.020","article-title":"Statins for hyperlipidemia in patients with chronic liver disease: are they safe?","volume":"4","author":"Vuppalanchi","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/hep.20671","article-title":"Statins and hepatotoxicity: focus on patients with fatty liver","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatol Baltim Md."},{"key":"B64","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1570161115666170621082910","article-title":"Statins: an under-appreciated asset for the prevention and the treatment of NAFLD or NASH and the related cardiovascular risk","volume":"16","author":"Athyros","year":"2018","journal-title":"Curr Vasc Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jhep.2018.07.019","article-title":"Statins: old drugs as new therapy for liver diseases?","volume":"70","author":"Pose","year":"2019","journal-title":"J Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1194\/jlr.M011080","article-title":"Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men","volume":"52","author":"Tremblay","year":"2011","journal-title":"J Lipid Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation."},{"key":"B68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1185\/030079908X253663","article-title":"Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia","volume":"24","author":"Assmann","year":"2008","journal-title":"Curr Med Res Opin."},{"key":"B69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3904\/kjim.2019.043","article-title":"The utility of ezetimibe therapy in nonalcoholic fatty liver disease","volume":"34","author":"Jun","year":"2019","journal-title":"Korean J Intern Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T11:10:19Z","timestamp":1617102619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":69,"alternative-id":["10.3389\/fmed.2020.00467"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00467","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"article-number":"467"}}